glp-1 and insulin resistance The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Non-insulin injectable antidiabetic drugs -

January 16, 2026: As Zepbound Drives Eli Lillys Revenue, More People File Lawsuits Claiming Injuries from the Drug In the federal MDL, there are 3,063 pending lawsuits against Eli Lilly and other GLP-1 drug makers (as of January 5, 2026)

Gel-forming antioxidant eye drop efficacy in rd10 mice Rod degeneration in rd10 mice is rapid after mice reach 2 weeks of age (Postnatal day 14, P14), around when pups open their eyes and topical eye drop treatment can be initiated

L-carnitine can be bought as a dietary supplement, but the nutrient is also added to energy drinks and some protein powders by manufacturers to try and enhance the value of their products

This isn't about rote instructions